Pediatric Melanoma
Showing 1 - 25 of >10,000
Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
Recruiting
- Uveal Melanoma
- blood sample examination
-
Catania, Italy
- +2 more
Dec 20, 2021
Metastatic Uveal Melanoma, Triple Negative Breast Cancer, Luminal B Breast Cancer Trial in Paris (Questionnaires,
Recruiting
- Metastatic Uveal Melanoma
- +3 more
- Questionnaires
- +3 more
-
Paris, FranceInstitut Curie
Apr 6, 2022
Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)
Recruiting
- Melanoma
- +4 more
- Pembrolizumab
-
Aurora, Colorado
- +18 more
Jan 5, 2023
Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma Trial in Washington (Cryoablation Therapy, Nivolumab, Ipilimumab)
Recruiting
- Osteosarcoma
- +9 more
- Cryoablation Therapy
- +2 more
-
Washington, District of ColumbiaChildren's National Hospital
Mar 21, 2022
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)
Recruiting
- Pediatric Solid Tumor
- +15 more
- Fludarabine
- +3 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Jun 30, 2022
Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Renal Cell Carcinoma Trial in Boston (GVAX)
Completed
- Sarcoma, Clear Cell
- +3 more
- GVAX
-
Boston, Massachusetts
- +1 more
Mar 2, 2021
Rhabdomyosarcoma, Melanoma Trial in United States (Tc99m tilmanocept, Vital Blue Dye (optional), Lymph Node Mapping)
Completed
- Rhabdomyosarcoma
- Melanoma
- Tc99m tilmanocept
- +2 more
-
Jacksonville, Florida
- +5 more
Mar 5, 2020
Recurrent Cutaneous Melanoma, Recurrent Lip and Oral Cavity Carcinoma, Recurrent Malignant Endocrine Tumor Trial in Houston
Recruiting
- Recurrent Cutaneous Melanoma
- +27 more
- Cord Blood-derived Expanded Allogeneic Natural Killer Cells
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Apr 28, 2021
Cutaneous Melanoma, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Orlando (Exercise Test)
Not yet recruiting
- Cutaneous Melanoma
- +2 more
- Exercise Test
-
Orlando, FloridaAdventHealth Translational Research Institute
Aug 18, 2023
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)
Active, not recruiting
- Malignant Melanoma
- Peginterferon alfa-2b
- +2 more
-
San Diego, California
- +2 more
Apr 1, 2022
Skin Lesion, Nevus Trial (DermTech PLA noninvasive adhesive biopsy)
Not yet recruiting
- Skin Lesion
- Nevus
- DermTech PLA noninvasive adhesive biopsy
- (no location specified)
Jun 13, 2022
Merkel Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Non-Melanoma Skin Cancers Trial in United States (IFx-Hu2.0)
Recruiting
- Merkel Cell Carcinoma
- +2 more
- IFx-Hu2.0
-
Los Angeles, California
- +3 more
Apr 4, 2022
Merkel Cell Carcinoma Trial in Worldwide (Pembrolizumab (MK-3475))
Active, not recruiting
- Merkel Cell Carcinoma
- Pembrolizumab (MK-3475)
-
New York, New York
- +21 more
Nov 30, 2022
Brain Tumor, Medulloblastoma, Brain Metastases Trial in Atlanta (WP1066)
Recruiting
- Brain Tumor
- +2 more
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta (CHOA)
Jul 24, 2022
PET Imaging of the Immune System Using Analog Probes
Completed
- Malignant Melanoma
- [18F] CFA
-
Los Angeles, CaliforniaUniversity of California, Los Angeles
Oct 8, 2021
Melanoma Trial in Worldwide (Pembrolizumab, Placebo)
Active, not recruiting
- Melanoma
- Pembrolizumab
- Placebo
-
Tucson, Arizona
- +158 more
Oct 31, 2022
Melanoma Trial in Memphis
Recruiting
- Melanoma
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 19, 2021
Psychoeducation for Uveal Melanoma
Not yet recruiting
- Uveal Melanoma
- Education for Intervention
- Best Practice
- (no location specified)
Oct 4, 2023
Malignant Melanomas Trial in Fuzhou (Recombinant Human Adenovirus Type 5 Injection)
Enrolling by invitation
- Malignant Melanomas
- Recombinant Human Adenovirus Type 5 Injection
-
Fuzhou, Fujian, ChinaFujian Cancer Hospital, Department of Internal Medicine, Ward 19
Jul 7, 2023
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)
Recruiting
- Colorectal Carcinoma
- +21 more
- Dual X-ray Absorptiometry
- +2 more
-
Birmingham, Alabama
- +18 more
Jan 30, 2023